About RestoreFlow Allografts
RestoreFlow Allografts is a Healthcare company based in Fox River Grove (United States) founded in 2013, and was acquired by LeMaitre Vascular in November 2016. Regenerative medicines from human tissues are developed for multiple diseases. RestoreFlow Allografts has raised $750 thousand across 1 funding round from investors including LeMaitre Vascular. Its chief executive, as recorded, is Torico D Jones. Its focus areas include Life Sciences, Regenerative Medicine, Bioartificial Organs and Wound Care. Its competitors include MiMedx Group, Satellite Bio and KaloCyte; 2 of its 3 listed competitors have raised funding.
Company details
RestoreFlow Allografts was established in 2013 in Fox River Grove, United States. Human tissue-based regenerative medicines are developed by the company to treat various diseases within the biotechnology sector. Operations center on research and production of these therapies. Leadership is held by CEO Torico D Jones, with activities conducted primarily in the U.S. market.
- Headquarters Fox River Grove, United States
- Stage Acquired
- SectorsHealthcare
- Website restoreflow.com
- Social X Facebook
- Acquired by LeMaitre Vascular (Nov 2016)
- Total Equity Funding$750K (USD)
in 1 rounds
- Latest Funding Round$750K (USD), Seed
Jun 2013
- Investors
- Acquired byLeMaitre Vascular
(Nov 2016)
Funding Insights of RestoreFlow Allografts
RestoreFlow Allografts has successfully raised a total of $750K through 1 strategic funding round. The most recent funding activity was a Seed round of $750 thousand completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $750,000
- Total Rounds 1
- Last Round Seed — $750,000
- First Round $750,000
(Jun 2013)
All 1 funding rounds of RestoreFlow Allografts with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2013 | $750,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in RestoreFlow Allografts
RestoreFlow Allografts has secured backing from 1 investor. Prominent investors backing the company include LeMaitre Vascular.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Devices for peripheral vascular disease treatment are developed and marketed. | 1983 | lemaitre.com | Burlington, United States |
Investor details for RestoreFlow Allografts
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RestoreFlow Allografts
1 people are tracked at RestoreFlow Allografts (1 in leadership).
| Name | Role | Group |
|---|---|---|
Torico D Jones | CEO | Leadership |
Complete people profiles for RestoreFlow Allografts
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RestoreFlow Allografts
3 dated milestones of RestoreFlow Allografts across 3 years, from founding to its latest funding, stage changes and deals.
- Founded RestoreFlow Allografts is founded.
- Funding First funding round of $750K.
- Exit Acquired by LeMaitre Vascular.
Competitors of RestoreFlow Allografts
RestoreFlow Allografts has 3 listed competitors in our database, 2 of them funded. They include MiMedx Group, Satellite Bio and KaloCyte.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mimedx.com | 1985 | Marietta, United States | 735 | Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | ||
| satellite.bio | 2019 | Cambridge, United States | $110M | 21 | Proprietary implantable satellite organs are developed for cell therapy. | |
| kalocyte.com | 2016 | St. Louis, United States | $1.1M | Nanotechnology-based red blood cell substitutes are developed. |
Detailed competitors of RestoreFlow Allografts
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Wound Care
3 companies that operate in the same segment as RestoreFlow Allografts (Wound Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | 35 | ||
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RestoreFlow Allografts
RestoreFlow Allografts was founded in 2013.
RestoreFlow Allografts is headquartered in Fox River Grove, United States. It is registered at Fox River Grove, Illinois, United States.
Torico D Jones is the CEO of RestoreFlow Allografts, as recorded in our data.
RestoreFlow Allografts is a funded company, having raised a total of $750K across 1 funding round to date. The company's 1st funding round was a Seed of $750K, raised on Jun 2013.
RestoreFlow Allografts was established in 2013 in Fox River Grove, United States. Human tissue-based regenerative medicines are developed by the company to treat various diseases within the biotechnology sector. Operations center on research and production of these therapies. Leadership is held by CEO Torico D Jones, with activities conducted primarily in the U.S. market.
RestoreFlow Allografts's top competitors include MiMedx Group, KaloCyte and Satellite Bio.
RestoreFlow Allografts has 1 investor. Key investors include LeMaitre Vascular.
Yes. RestoreFlow Allografts was acquired by LeMaitre Vascular in November 2016.